Marc Apple, MD

Appointed
2022

Education & Fellowships

Residency - Henry Ford Hospital
Radiation Oncology
Detroit,
1998

Residency - University of Connecticut Health Sciences Center
Nuclear Medicine
Farmington, CT
1995

Residency - Orlando Regional Medical Center
General Surgery
Orlando, FL
1993

Medical Education - University of Miami
Coral Gables, FL
1990

Professional Highlights

• Dr. Apple has been active in clinical research and innovation over past several years. He has been an NCI site investigator; participated in several national and international clinical research protocols and providing peer teaching in new technology applications.
• Dr. Apple has had several research articles published within multiple medical peer reviewed journals and specialty texts. He has presented at several cross discipline specialty meetings/symposiums over the years and provided consultation to multiple international medical device companies prior to joining Cleveland Clinic.
• He has received state and national society level awards for novel research and innovation developments. Dr. Marc Apple has been issued at least 10 US/Intl patents, as primary inventor, for medical devices since the 1990's.

Certifications

• Radiology - Radiation Oncology

Specialty Interests

General Radiation Oncology; Stereotactic Radiosurgery/Radiotherapy; HDR/LDR/Applicator brachytherapy techniques; IMRT/IGRT external beam radiotherapy; Therapeutic Nuclear Medicine techniques

Awards & Honors

•  

Innovations & Patents

• Dr. M. Apple holds as primary inventor at least 10 Issued U.S/Intl patents in the medical device arena.

Memberships

• AMA; ASTRO; ABR; ACR; ABR

See publications for Marc Apple, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 4/17/2024, Dr. Apple has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.